Tag

UF Cancer Center

UF Health Recognized As National Leader for Treatment of Rare Inherited Disorder

UF Health has become one of only 40 VHL Alliance Clinical Care Centers in the United States. The VHL Alliance is made up of leading healthcare organizations that specialize in treating von Hippel-Lindau (VHL) syndrome, a rare inherited disorder associated with tumors. Hans Shuhaiber, M.D., a clinical assistant professor in the department of neurology in the UF College of Medicine and a member of the UF Health Cancer Center, said this recognition will ensure patients have access to the best treatment when they come to UF Health.

University of Florida Researchers Unlock New Frontiers in Brain Tumor Treatments

Researchers at the University of Florida's are making breakthroughs in the treatment of malignant brain tumors. Duane Mitchell, M.D., Ph.D., co-directs the teams conducting this research at the Preston A. Well Jr. Center for Brain Tumor Therapy at UF Health. Over the past ten years, the center has received FDA approval on 12 therapeutics and launched 13 novel immunotherapy clinical trials.

UF Nursing Researchers Provide Parents CHOICES for Reproductive Health

Two University of Florida College of Nursing researchers earned a four-year $3 million grant to support a large national study to test the effect of a web-based educational tool that aims to help young adults understand sickle cell disease — or even prevent it from being inherited.

The V Foundation Announces Renewed Research Support for UF’s Dr. Duane Mitchell

During the 16th annual Dick Vitale Gala, the V Foundation for Cancer Research announced that Duane Mitchell, M.D., Ph.D., director of the UF Clinical and Translational Science Institute, assistant vice president for research at UF and co-leader of the UF Health Cancer Center’s Cancer Therapeutics & Host Response research program, will receive additional support for his research on brain cancer in children.